Publications

Found 465 results
2017
Martinez-Murillo P, Tran K, Guenaga J, Lindgren G, dori MÀ, Feng Y, Phad GE, Bernat NVázquez, Bale S, Ingale J et al..  2017.  Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.. Immunity. 46(5):804-817.e7.
Mengistu M, Tang A-H, Foulke JS, Blanpied TA, Gonzalez MW, Spouge JL, Gallo RC, Lewis GK, DeVico AL.  2017.  Patterns of conserved gp120 epitope presentation on attached HIV-1 virions.. Proc Natl Acad Sci U S A. 114(46):E9893-E9902.
Escolano A, Dosenovic P, Nussenzweig MC.  2017.  Progress toward active or passive HIV-1 vaccination.. J Exp Med. 214(1):3-16.
Barouch DH, Thomas SJ, Michael NL.  2017.  Prospects for a Zika Virus Vaccine.. Immunity. 46(2):176-182.
Julg B, Liu P-T, Wagh K, Fischer WM, Abbink P, Mercado NB, Whitney JB, Nkolola JP, McMahan K, Tartaglia LJ et al..  2017.  Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.. Sci Transl Med. 9(408)
Julg B, Sok D, Schmidt SD, Abbink P, Newman RM, Broge T, Linde C, Nkolola J, Le K, Su D et al..  2017.  Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.. J Virol. 91(20)
Sok D, Le KM, Vadnais M, Saye-Francisco K, Jardine JG, Torres J, Berndsen ZT, Kong L, Stanfield R, Ruiz J et al..  2017.  Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows.. Nature. 548(7665):108-111.
Robbiani DF, Bozzacco L, Keeffe JR, Khouri R, Olsen PC, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R et al..  2017.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.. Cell. 169(4):597-609.e11.
Baxter AE, Niessl J, Morou A, Kaufmann DE.  2017.  RNA flow cytometric FISH for investigations into HIV immunology, vaccination and cure strategies.. AIDS Res Ther. 14(1):40.
Koch K, Kalusche S, Torres JL, Stanfield RL, Danquah W, Khazanehdari K, von Briesen H, Geertsma ER, Wilson IA, Wernery U et al..  2017.  Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.. Sci Rep. 7:8390.
Behrens A-J, Crispin M.  2017.  Structural principles controlling HIV envelope glycosylation.. Curr Opin Struct Biol. 44:125-133.
Wibmer CKurt, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, M Joyce G, Ndabambi N et al..  2017.  Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.. PLoS Pathog. 13(1):e1006074.
Kulp DW, Steichen JM, Pauthner M, Hu X, Schiffner T, Liguori A, Cottrell CA, Havenar-Daughton C, Ozorowski G, Georgeson E et al..  2017.  Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.. Nat Commun. 8(1):1655.
Martinez-Martin N, Maldonado P, Gasparrini F, Frederico B, Aggarwal S, Gaya M, Tsui C, Burbage M, Keppler SJessica, Montaner B et al..  2017.  A switch from canonical to noncanonical autophagy shapes B cell responses.. Science. 355(6325):641-647.
Polonskaya Z, Deng S, Sarkar A, Kain L, Comellas-Aragones M, McKay CS, Kaczanowska K, Holt M, McBride R, Palomo V et al..  2017.  T cells control the generation of nanomolar-affinity anti-glycan antibodies.. J Clin Invest. 127(4):1491-1504.
Hopper JTS, Ambrose S, Grant OC, Krumm SA, Allison TM, Degiacomi MT, Tully MD, Pritchard LK, Ozorowski G, Ward AB et al..  2017.  The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans.. Structure. 25(5):773-782.e5.
Havenar-Daughton C, Lee J H, Crotty S.  2017.  Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.. Immunol Rev. 275(1):49-61.
Xu L, Pegu A, Rao E, Doria-Rose N, Beninga J, McKee K, Lord DM, Wei RR, Deng G, Louder M et al..  2017.  Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.. Science. 358(6359):85-90.
Martins MA, Shin YC, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Castro I, Magnani DM, Ricciardi M, Pedreño-Lopez N et al..  2017.  Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.. PLoS Pathog. 13(7):e1006529.
Julg B, Pegu A, Abbink P, Liu J, Brinkman A, Molloy K, Mojta S, Chandrashekar A, Callow K, Wang K et al..  2017.  Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.. J Virol. 91(16):pii:e00498-17.
Burton DR.  2017.  What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise. Cold Spring Harb Perspect Biol. :pii:a030262.
Bowen JR, Quicke KM, Maddur MS, O'Neal JT, McDonald CE, Fedorova NB, Puri V, Shabman RS, Pulendran B, Suthar MS.  2017.  Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells.. PLoS Pathog. 13(2):e1006164.
Aid M, Abbink P, Larocca RA, Boyd M, Nityanandam R, Nanayakkara O, Martinot AJ, Moseley ET, Blass E, Borducchi EN et al..  2017.  Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys.. Cell. 169(4):610-620.e14.

Pages